This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Research Article
Maurice M. Iwu
Bioresources Institute of Nigeria
Corresponding Author
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Andrographolide (1) a bitter, diterpenes lactone is the most biologically active constituent from Andrographis paniculata. Andrographolide showed in vitro inhibition of the growth of Ebola virus (Zaire) with EC50 activity of 10 µM which is twenty-five-fold the activity of the control Favipiravir (EC50 = 250µM) in the Crystal violet (Plaque reduction/ Neutral red (Toxicity) assay. It also showed significant activity against Dengue fever virus with EC50 value of 0.56 µg/ml in the Visual (Cytopathic effect/ Toxicity) Assay and EC50 of 0.58 µg/ml in the Neutral Red (Cytopathic effect/ Toxicity) Assay (comparable to the values obtained with 6-Azauridine as the positive control EC50 = 0.32 µg/ml and 0.38 µg/ml in the respective bioassays; and against SARS Coronavirus. Andrographolide had an EC50 of 1.2 µg/ml in the Visual (cytopathic effect/toxicity) assay and 1.1 µg/ml in the Neutral Red (cytopathic effect/toxicity) assay. The compound exerts several immunomodulatory properties. In experimental models, it effectively reduced the levels of proinflammatory cytokines such as IL-1/3, IL-6, GMCSF, and TNF-a. The compound has a good pharmacokinetics profile and relatively non-toxic even at high doses making it an experimental drug for the treatment of viral infections, with possible application in the control of the Novel Coronavirus, Covid – 19.
Keywords
Andrographolide, in vitro inhibition, Ebola virus, Dengue fever virus, SARS Coronavirus
Figure 1
Loading...
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
History
CURRENT STATUS: Posted
Version 1
Posted 30 Apr, 2020
Community comments: 1
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Subject Areas
Pharmacokinetics
Learn more about our company.
This is a preprint. It has not completed peer review.
Research Article
Maurice M. Iwu
Bioresources Institute of Nigeria
Corresponding Author
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
History
CURRENT STATUS: Posted
Version 1
Posted 30 Apr, 2020
Community comments: 1
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Subject Areas
Pharmacokinetics
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Andrographolide (1) a bitter, diterpenes lactone is the most biologically active constituent from Andrographis paniculata. Andrographolide showed in vitro inhibition of the growth of Ebola virus (Zaire) with EC50 activity of 10 µM which is twenty-five-fold the activity of the control Favipiravir (EC50 = 250µM) in the Crystal violet (Plaque reduction/ Neutral red (Toxicity) assay. It also showed significant activity against Dengue fever virus with EC50 value of 0.56 µg/ml in the Visual (Cytopathic effect/ Toxicity) Assay and EC50 of 0.58 µg/ml in the Neutral Red (Cytopathic effect/ Toxicity) Assay (comparable to the values obtained with 6-Azauridine as the positive control EC50 = 0.32 µg/ml and 0.38 µg/ml in the respective bioassays; and against SARS Coronavirus. Andrographolide had an EC50 of 1.2 µg/ml in the Visual (cytopathic effect/toxicity) assay and 1.1 µg/ml in the Neutral Red (cytopathic effect/toxicity) assay. The compound exerts several immunomodulatory properties. In experimental models, it effectively reduced the levels of proinflammatory cytokines such as IL-1/3, IL-6, GMCSF, and TNF-a. The compound has a good pharmacokinetics profile and relatively non-toxic even at high doses making it an experimental drug for the treatment of viral infections, with possible application in the control of the Novel Coronavirus, Covid – 19.
Figure 1
Loading...